GHRH & GH Secretagogue Peptides Wholesale

What this class covers

This class holds two families of research peptide that buyers nearly always order together, so the catalog keeps them in one place. The first is the GHRH analogues: synthetic variants of growth hormone-releasing hormone. Tesamorelin is an analogue of the full 44-residue hormone, GHRH(1-44), and is the heaviest peptide in the class at 5136 g/mol. CJC-1295 no DAC is a modified GHRH analogue supplied without the drug affinity complex.

The second family is the secretagogue peptides, which are short synthetic sequences rather than hormone analogues. GHRP-2, also indexed as pralmorelin, is a hexapeptide at 818.0 g/mol built with D-amino acids and a C-terminal amide; its sequence includes 3-(2-naphthyl)alanine, a non-standard residue. Alongside them sits one pre-combined vial, CJC-1295 + Ipamorelin, which puts 5 mg of each peptide in a single 10 mg vial.

As materials, all four are peptide powders in sealed vials, listed in milligrams per vial. The descriptions above are structural: what the molecule is and how it is made, taken from the identity data on each product page. Nothing here describes what any of them does.

What we list in this class

Two of the four carry a report matched to the product and size, and two carry a reference report. The Published purity and Report columns above are read from the report data, so they always show the current state rather than a snapshot of it. Each product page lists every report published for that compound, matched and reference alike.

If the DAC form is what you want, note the distinction carefully: the vial we stock is CJC-1295 without the drug affinity complex. The albumin-binding, long-acting CJC-1295 with DAC is a separate material and we source it to order.

• CJC-1295 no DAC - 10 mg. The published report is a reference report: a Horizon Analytical document on a 5 mg vial from a batch shared with our partner Genesis Biomapping, giving identity by UPLC/MS with no purity figure printed.
• GHRP-2 - 5 mg. Published report at 5 mg, matched to the size listed.
• Tesamorelin - 5 mg and 10 mg. The published report is a reference report on the 10 mg lot, again a partner batch under their lot number; no report is published for the 5 mg size.
• CJC-1295 + Ipamorelin - 10 mg total, 5 mg of each component. Published report at 10 mg, matched to the size listed.

What the published reports cover

The Kovera Labs reports in this class print purity by RP-HPLC at 214 nm, identity by LC-MS and a net content check in milligrams. The GHRP-2 report prints 99.412%; the CJC-1295 + Ipamorelin report prints a blend average purity of 99.459%, which is one figure across the two components rather than a purity for each. Both are quoted here exactly as the documents print them.

The Horizon Analytical reports behind CJC-1295 no DAC and Tesamorelin were issued to Genesis Biomapping, a partner we share batches with, and they carry that partner's lot numbers. The Tesamorelin document prints 99.39% purity by UPLC/MS. The CJC-1295 no DAC document prints identity only, with no purity figure at all, and the page says so rather than borrowing a number from somewhere else.

No report in this class establishes that its printed batch is the batch now on the shelf. Your quote names the lot you would receive and that lot's report, and every wholesale lot ships with its certificate of analysis. The three single compounds each have a publication statistics page under the product page, counting the indexed literature by name; the hub is /research.

How to order from this class

Sizes are per vial and quantity is the number of vials. No prices are published anywhere in the catalog and no minimum order is published either: send the list as you want it and the quote comes back against that list.

Mixing is normal here. A single inquiry can hold Tesamorelin at both 5 mg and 10 mg, GHRP-2 at 5 mg, the pre-combined CJC-1295 + Ipamorelin vial, and anything from peptides or blends in the same message. If part of the list is a compound we source rather than stock, say so in the same message and the quote covers both halves.

What comes back names pricing, current availability, the lot and its report. Stock ships from Tampa Bay, Florida to the United States; factory-direct volumes ship from the manufacturer and can go internationally. How ordering works has the sequence end to end.

White label and 3PL in this class

GHRH analogues and secretagogues are a common second line for a research brand that started on a couple of single peptides, and they white-label the same way. White label covers your label, vial and carton from these lots. 3PL fulfillment holds your finished stock in Tampa Bay and ships it under your brand.

Worth deciding early: whether you want the pre-combined CJC-1295 + Ipamorelin vial on your line in addition to the single compounds, since it is one SKU covering what would otherwise be two, and whether you want the with-DAC form as well, which we source rather than stock. Bring the compounds, the sizes and the vial count you have in mind and the quote confirms what is available.

What we source beyond these four

This is the class where the sourced-to-order list is longest, because most of the family is not stocked.

• GHRH analogues and secretagogues we source: CJC-1295 with DAC, Sermorelin, Ipamorelin as a single vial, Hexarelin Acetate and GHRP-6.
• Growth-factor-related peptides we source: MGF, PEG-MGF, HGH Fragment 176-191 and AOD-9604.
• A sourced compound is not in stock, and its page says exactly that: what the material is, that we get it to order, and that availability, sizes and pricing come back on the quote. See everything we source.